From Anvita Health Wiki
Introduction
- Salmon calicitonin: Tradenames: Calcimar, Miacalcin. Human calcitonin: Tradename: Cibacalcin.
Indications
-
-
Contraindications
Dosage
- 1 unit/0.1 mL SC inner aspect of arm (dilution required)
- observe injection site for 15 minutes for wheal or significant erythema
- 0.5 mg SC or IM QD
- volumes > 2 mL require IM injection
-
- 200 IU/actuation. 2 mL, 14 doses.
Pharmacokinetics
-
Adverse-effects
-
- frequency of urination
- with nasal administration
-
-
-
-
Mechanism-of-action
- inhibits osteoclastic bone resorption
-
More General Terms
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
Cibacalcin (calcitonin, Calcimar, Miacalcin)